Revue Neurologique 2021 Mar 30; doi: 10.1016/j.neurol.2020.11.012. Anne Donnet , Anne Ducros , Françoise Radat , Bashar Allaf , Isabelle Chouette , Michel Lanteri-Minet Abstract Currently many patients with severe migraine do not receive appropriate treatment and are never referred to specialist headache centres.
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
Cephalalgia 2021 Jan 20;333102421989247 doi: 10.1177/0333102421989247. Online ahead of print. Hans Christoph Diener , Messoud Ashina, Isabelle Durand-Zaleski, Tobias Kurth, Michel Lantéri-Minet, Richard B Lipton, Daniel A Ollendorf, Patricia Pozo-Rosich, Cristina Tassorelli, Gisela Terwindt Abstract The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study
Journal of neurology, neurosurgery, and psychiatry 2021 Jan 5;jnnp-2020-324396 doi: 10.1136/jnnp-2020-324396. Online ahead of print. Michel Lanteri-Minet, Peter J Goadsby, Uwe Reuter, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt Objective: To evaluate the effect of erenumab on patient-reported, functional outcomes in patients with episodic
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
THE LANCET Neurology Volume 19, ISSUE 10, P814-825, October 01, 2020 Wim M Mulleners, Byung-Kun Kim, Miguel J A Láinez, Michel Lanteri-Minet, Patricia Pozo-Rosich, Shufang Wang, Antje Tockhorn-Heidenreich, Sheena K Aurora, Russell M Nichols, Laura Yunes-Medina, Holland C Detke. Background Many patients who require migraine preventive treatment have not been
Étude de phase III, contrôlée, randomisée, de supériorité de galcanézumab versus placebo, chez les patients atteints de migraine difficile à traiter : résultats de l’étude CONQUER
Vol 176 – N° S – septembre 2020 P. S2-S148 © Elsevier Masson SAS Journées de Neurologie de Langue Française 2020 Wim M Mulleners, Byungkun Kim , Miguel Ja Láinez, Michel Lanteri-Minet, , Sheena K Aurora, Russell M Nichols ,
Headaches during pregnancy
Revue Neurologique (Paris). 2020 Aug 21;S0035-3787(20)30622-6. doi: 10.1016/j.neurol.2020.05.012. Online ahead of print. Headaches during pregnancy S de Gaalon 1 , A Donnet 2 PMID: 32838992 DOI: 10.1016/j.neurol.2020.05.012 Abstract Headache during pregnancy is frequent and challenging. A secondary headache is diagnosed in
Migraine and Two-Pore-Domain Potassium Channels
The Neuroscientist. 2020 Jul 27;1073858420940949. doi: 10.1177/1073858420940949. Online ahead of print. Migraine and Two-Pore-Domain Potassium Channels Clément Verkest, Stephanie Häfner, Pablo Ávalos Prado, Anne Baron, Guillaume Sandoz PMID: 32715910 DOI: 10.1177/1073858420940949 Abstract Migraine is a common, disabling neurological disorder with a genetic, environmental, and
Two-pore-domain potassium channels and molecular mechanisms underlying migraine
Biologie Aujourd’hui 2019;213(1-2):51-57. doi: 10.1051/jbio/2019020. Epub 2019 Jul 5. [Two-pore-domain potassium channels and molecular mechanisms underlying migraine] Perrine Royal, Pablo Ávalos Prado, Brigitte Wdziekonski, Guillaume Sandoz PMID: 31274103 DOI: 10.1051/jbio/2019020 Abstract Migraine is a common, disabling neurological disorder with genetic, environmental and hormonal
Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK.
Neuron. 2019 Jan 16;101(2):232-245.e6. doi: 10.1016/j.neuron.2018.11.039. Epub 2018 Dec 17. Royal P1, Andres-Bilbe A2, Ávalos Prado P1, Verkest C3, Wdziekonski B1, Schaub S4, Baron A5, Lesage F3, Gasull X2, Levitz J6, Sandoz G7. Abstract It is often unclear why some
Effects of systemic inhibitors of Acid-Sensing Ion Channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.
Br J Pharmacol. 2018 Nov;175(21):4154-4166. doi: 10.1111/bph.14462. Epub 2018 Sep 22. Verkest C1,2,3, Piquet E3,4, Diochot S1,2,3, Dauvois M1, Lanteri-Minet M3,4,5, Lingueglia E1,2,3, Baron A1,2,3. Abstract BACKGROUND AND PURPOSE: Acid-sensing ion channels (ASICs) are neuronal proton sensors emerging as potential